Literature DB >> 20580617

Familial C4B deficiency and immune complex glomerulonephritis.

K Soto1, Y L Wu, A Ortiz, S R Aparício, C Y Yu.   

Abstract

Homozygous complement C4B deficiency is described in a Southern European young female patient with Membranoproliferative Glomerulonephritis (MPGN) type III characterized by renal biopsies with strong complement C4 and IgG deposits. Low C4 levels were independent of clinical evolution or type of immunosuppression and were found in three other family members without renal disease or infections. HLA typing revealed that the patient has homozygous A*02, Cw*06, B*50 at the class I region, and DRB1*08 and DQB1*03 at the class II region. Genotypic and phenotypic studies demonstrated that the patient has homozygous monomodular RCCX in the HLA class III region, with single long C4A genes coding for C4A3 and complete C4B deficiency. Her father, mother, son and niece have heterozygous C4B deficiency. The patient's deceased brother had a history of Henoch-Schönlein Purpura (HSP), an immune complex-mediated proliferative glomerulonephritis. These findings challenge the putative pathophysiological roles of C4A and C4B and underscore the need to perform functional assays, C4 allotyping and genotyping on patients with persistently low serum levels of a classical pathway complement component and glomerulopathy associated with immune deposits.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580617      PMCID: PMC2941544          DOI: 10.1016/j.clim.2010.06.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  47 in total

1.  Childhood membranoproliferative glomerulonephritis: an approach to management.

Authors:  C D West
Journal:  Kidney Int       Date:  1986-05       Impact factor: 10.612

2.  Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.

Authors:  W S Varade; J Forristal; C D West
Journal:  Am J Kidney Dis       Date:  1990-09       Impact factor: 8.860

3.  Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura.

Authors:  R H McLean; R J Wyatt; B A Julian
Journal:  Kidney Int       Date:  1984-12       Impact factor: 10.612

4.  Immunosuppressive treatment of membranoproliferative glomerulonephritis.

Authors:  R Faedda; A Satta; F Tanda; M Pirisi; E Bartoli
Journal:  Nephron       Date:  1994       Impact factor: 2.847

5.  C4 isotype deficiency in IgA nephropathy.

Authors:  T R Welch; A Berry; L S Beischel
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

6.  Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes.

Authors:  Yee Ling Wu; Stephanie L Savelli; Yan Yang; Bi Zhou; Brad H Rovin; Daniel J Birmingham; Haikady N Nagaraja; Lee A Hebert; C Yung Yu
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

7.  Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases.

Authors:  H Schmitt; A Bohle; T Reineke; D Mayer-Eichberger; W Vogl
Journal:  Nephron       Date:  1990       Impact factor: 2.847

8.  Epidemiology of primary glomerular diseases in a French region. Variations according to period and age.

Authors:  P Simon; M P Ramée; V Autuly; E Laruelle; C Charasse; G Cam; K S Ang
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

Review 9.  Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.

Authors:  Christoph Licht; Veronique Fremeaux-Bacchi
Journal:  Thromb Haemost       Date:  2009-02       Impact factor: 5.249

10.  Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans.

Authors:  Timothy J Aitman; Rong Dong; Timothy J Vyse; Penny J Norsworthy; Michelle D Johnson; Jennifer Smith; Jonathan Mangion; Cheri Roberton-Lowe; Amy J Marshall; Enrico Petretto; Matthew D Hodges; Gurjeet Bhangal; Sheetal G Patel; Kelly Sheehan-Rooney; Mark Duda; Paul R Cook; David J Evans; Jan Domin; Jonathan Flint; Joseph J Boyle; Charles D Pusey; H Terence Cook
Journal:  Nature       Date:  2006-02-16       Impact factor: 49.962

View more
  6 in total

Review 1.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

2.  Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

Authors:  Lora Boteva; David L Morris; Josefina Cortés-Hernández; Javier Martin; Timothy J Vyse; Michelle M A Fernando
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

3.  Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects.

Authors:  Xiaobo Yang; Jielin Sun; Yong Gao; Aihua Tan; Haiying Zhang; Yanling Hu; Junjie Feng; Xue Qin; Sha Tao; Zhuo Chen; Seong-Tae Kim; Tao Peng; Ming Liao; Xiaoling Lin; Zengfeng Zhang; Minzhong Tang; Li Li; Linjian Mo; Zhengjia Liang; Deyi Shi; Zhang Huang; Xianghua Huang; Ming Liu; Qian Liu; Shijun Zhang; Jeffrey M Trent; S Lilly Zheng; Jianfeng Xu; Zengnan Mo
Journal:  PLoS Genet       Date:  2012-09-13       Impact factor: 5.917

4.  Medical Records-Based Genetic Studies of the Complement System.

Authors:  Atlas Khan; Ning Shang; Lynn Petukhova; Jun Zhang; Yufeng Shen; Scott J Hebbring; Halima Moncrieffe; Leah C Kottyan; Bahram Namjou-Khales; Rachel Knevel; Soumya Raychaudhuri; Elizabeth W Karlson; John B Harley; Ian B Stanaway; David Crosslin; Joshua C Denny; Mitchell S V Elkind; Ali G Gharavi; George Hripcsak; Chunhua Weng; Krzysztof Kiryluk
Journal:  J Am Soc Nephrol       Date:  2021-05-03       Impact factor: 14.978

5.  Clinical features of patients with homozygous complement C4A or C4B deficiency.

Authors:  Inka Liesmaa; Riitta Paakkanen; Asko Järvinen; Ville Valtonen; Marja-Liisa Lokki
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

6.  Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune Diseases.

Authors:  Danlei Zhou; Michael Rudnicki; Gilbert T Chua; Simon K Lawrance; Bi Zhou; Joanne L Drew; Fatima Barbar-Smiley; Taylor K Armstrong; Miranda E Hilt; Daniel J Birmingham; Werner Passler; Jeffrey J Auletta; Sasigarn A Bowden; Robert P Hoffman; Yee Ling Wu; Wael N Jarjour; Chi Chiu Mok; Stacy P Ardoin; Yu Lung Lau; Chack Yung Yu
Journal:  Front Immunol       Date:  2021-10-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.